What is Alio?
Alio operates at the intersection of medical technology and data analytics, addressing the systemic inefficiencies inherent in current remote patient monitoring solutions. The company distinguishes itself by moving away from invasive, single-metric devices that often suffer from poor user compliance and fragmented data outputs. Instead, Alio leverages proprietary technology to generate clinical-grade, accurate insights that are both actionable and scalable.
By synthesizing complex health metrics into a unified, user-friendly interface, Alio enhances the efficacy of chronic condition management. Its platform is designed to bridge the gap between raw sensor data and meaningful clinical outcomes, offering a sophisticated alternative to off-the-shelf fitness trackers that lack the precision required for professional medical oversight. The versatility of this technology suggests a significant competitive advantage, with potential utility extending well beyond the clinical environment into diverse sectors requiring high-fidelity remote monitoring.
How much funding has Alio raised?
Alio has raised a total of $49M across 3 funding rounds:
Series A
$11M
Series B
$20M
Series C
$18M
Series A (2018): $11M, investors not publicly disclosed
Series B (2021): $20M led by Zekavat Investment Group and Thomas Krebs
Series C (2022): $18M supported by Chase Field, Widjaja Family Investment Office, and LLC
Key Investors in Alio
Chase Field
A diversified investment entity with interests in strategic growth opportunities and large-scale infrastructure projects.
Zekavat Investment Group
A private investment firm focused on identifying and scaling high-potential technology ventures within the healthcare and data sectors.
Widjaja Family Investment Office
A family office vehicle providing long-term capital support to innovative companies with significant market disruption potential.
What's next for Alio?
With the recent infusion of capital, Alio is poised to accelerate its enterprise-level expansion. The strategic focus will likely center on scaling its operational capacity to meet the demands of large-scale healthcare providers and industrial partners. By prioritizing the integration of its actionable insights into existing clinical workflows, the company aims to solidify its market position as a leader in the remote monitoring space.
Future growth will be driven by the continued refinement of its data aggregation engine and the pursuit of new market verticals. As Alio matures, the emphasis will shift toward long-term sustainability and the establishment of a dominant ecosystem for remote health and industrial monitoring, ensuring that its clinical-grade data remains the gold standard for accuracy and user experience.
